Testing effectiveness (Phase 2)Active Not RecruitingNCT06547216
What this trial is testing
Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
Who this might be right for
FSHDFSHD1FSHD2+24 more
Avidity Biosciences, Inc. 84